Publications by authors named "Michael Frezza"

Claim this Profile
N
New applications of old metal-binding drugs in the treatment of human cancer.
Sara M Schmitt, Michael Frezza, Qing Ping Dou

Front Biosci (Schol Ed)· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy.
Michael Frezza, Sara Schmitt, Q Ping Dou

Curr Top Med Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli.
Michael Frezza, Huanjie Yang, Q Ping Dou

J Cell Physiol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands.
Michael Frezza, Q Ping Dou, Yan Xiao, Hamidreza Samouei, Mehdi Rashidi

J Med Chem· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel metals and metal complexes as platforms for cancer therapy.
Michael Frezza, Sarmad Hindo, Di Chen, Andrew Davenport, Sara Schmitt

Curr Pharm Des· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells.
Andrew Davenport, Michael Frezza, Min Shen, Yubin Ge, Congde Huo

Int J Mol Med· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and -independent processes.
Xia Zhang, Michael Frezza, Vesna Milacic, Luca Ronconi, Yuhua Fan

J Cell Biochem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.
Sarmad Sahiel Hindo, Michael Frezza, Dajena Tomco, Mary Jane Heeg, Lew Hryhorczuk

Eur J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.
Michael Frezza, Sarmad Sahiel Hindo, Dajena Tomco, Marco M Allard, Qiuzhi Cindy Cui

Inorg Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metal complexes, their cellular targets and potential for cancer therapy.
Di Chen, Vesna Milacic, Michael Frezza, Q Ping Dou

Curr Pharm Des· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor activity of N-thiolated beta-lactam antibiotics.
Di Chen, Samuel C Falsetti, Michael Frezza, Vesna Milacic, Aslamuzzaman Kazi

Cancer Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of tumor cell apoptosis by a novel class of N-thiolated beta-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring.
Michael Frezza, Julio Garay, Di Chen, Cindy Cui, Edward Turos

Int J Mol Med· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.
Di Chen, Michael Frezza, Rajendra Shakya, Qiuzhi Cindy Cui, Vesna Milacic

Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis